ArticleHormone research in paediatrics2026
Glucose Management in Children Living with Type 1 Diabetes: Results from the BETTER Registry.
Article in Hormone research in paediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Behaviors, Therapies, Technologies, and Hypoglycemic Risk in Type 1 Diabetes (BETTER) Registry collects patient-reported outcomes and experiences on individuals living with type 1 diabetes in Canada. The objective of our study was to describe the management of type 1 diabetes reported by parents of children and young adolescents (<14 years of age) enrolled in the BETTER registry.
methodsWe conducted a cross-sectional evaluation using self-reported data collected from April 2019 to October 2024. Parents of children and adolescents <14 years self-registered and provided online informed consent. As of October 2024, 699 children and adolescents <14 years of age and living with type 1 diabetes were enrolled.
resultsChildren had a mean age of 8.8 ± 3.1 years old with a diabetes duration of 2.3 ± 2.7 years, 44.9% were female, and 85.0% were of European ancestry. More than 80% used a continuous glucose monitoring system and 38.3% used an insulin pump. Most recent HbA1c ≤7% was reported by 15.9% of participants. At least 1 episode of level 2 hypoglycemia (glucose levels <3.0 mmol/L, with ability to self-treat) in the last month was reported by 72.5% of participants, with a median number of episodes (interquartile range) of 5 (2, 10). The occurrence of level 3 hypoglycemia (low glucose, requiring help from another person, use of glucagon, hospitalization, or loss of consciousness) in the last 12 months was reported by 8.6% of participants. Among these, the median number of episodes was 1 (1, 3).
conclusionOur results indicate that, despite a wide use of continuous glucose monitoring, the occurrence of hypoglycemia is still high and the proportion of children and adolescents reaching the HbA1c target is low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.